In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis

被引:38
作者
Athamna, A
Athamna, M
Medlej, B
Bast, DJ
Rubinstein, E [1 ]
机构
[1] Tel Aviv Univ, Sch Med, Dept Human Microbiol, IL-69978 Tel Aviv, Israel
[2] Triangle Res & Dev Ctr, Kfar Qaraa, Israel
[3] Tel Aviv Univ, Sch Med, Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Tel Hashomer, Israel
[4] Mt Sinai Hosp, Dept Microbiol, ToCARE, Toronto, ON M5G 1X5, Canada
关键词
anthrax; PAE; susceptibility;
D O I
10.1093/jac/dkh130
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of this study was to investigate in vitro the post-antibiotic effect (PAE) of 19 antibacterial agents against two strains of Bacillus anthracis (ST-1 and Sterne strains). Methods: PAE was determined by calculating the time required for the viable counts of antibiotic-exposed bacteria (at concentrations of 10x MIC and exposure for 2 h) at 37degreesC to increase by 1 log(10) above the counts observed immediately after antibiotic removal compared with the corresponding time for controls not exposed to antibiotics. Results: The PAEs of the fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin and garenoxacin) were 2-5 h. The macrolide (erythromycin, clarithromycin and telithromycin) PAEs were 1-4 h, and that of clindamycin was 2 h. The PAEs induced by tetracycline and minocycline were 1-3 h. The PAEs induced by the beta-lactams (penicillin G, amoxicillin and ceftriaxone), vancomycin, linezolid and chloramphenicol were 1-2 h. The PAE induced by rifampicin was 4-5 h. Quinupristin/dalfopristin had the longest PAE, lasting for 7-8 h. Conclusions: Our results indicate that the PAE is unrelated to the MIC but may be related to the rapidity of bacterial kill. These observations may bear importance on treatment regimens of human anthrax.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 23 条
[1]   In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity [J].
Athamna, A ;
Massalha, M ;
Athamna, M ;
Nura, A ;
Medlej, B ;
Ofek, I ;
Bast, D ;
Rubinstein, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) :247-251
[2]  
Bigger J.W., 1944, Irish Journal of Medical Science, V6, P585, DOI [10.1007/BF02948386, DOI 10.1007/BF02948386]
[3]  
BUSTAMENTE CI, 1984, ANTIMICROB AGENTS CH, V5, P678
[4]   EVALUATION OF THE BACTERICIDAL ACTIVITY OF BETA-LACTAM ANTIBIOTICS ON SLOWLY GROWING BACTERIA CULTURED IN THE CHEMOSTAT [J].
COZENS, RM ;
TUOMANEN, E ;
TOSCH, W ;
ZAK, O ;
SUTER, J ;
TOMASZ, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) :797-802
[5]  
Craig W. A., 1999, ANTIBIOTICS LAB MED, P403
[7]   THE SLOW RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN [J].
EAGLE, H ;
MUSSELMAN, AD .
JOURNAL OF BACTERIOLOGY, 1949, 58 (04) :475-490
[8]   INTEGRATION OF PHARMACOKINETICS AND PHARMACODYNAMICS OF METHICILLIN IN CURATIVE TREATMENT OF EXPERIMENTAL ENDOCARDITIS [J].
GENGO, FM ;
MANNION, TW ;
NIGHTINGALE, CH ;
SCHENTAG, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (06) :619-631
[9]   ONCE-DAILY AMINOGLYCOSIDE THERAPY [J].
GILBERT, DN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :399-405
[10]   Anthrax as a biological weapon, 2002 - Updated recommendations for management [J].
Inglesby, TV ;
O'Toole, T ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Friedlander, AM ;
Gerberding, J ;
Hauer, J ;
Hughes, J ;
McDade, J ;
Osterholm, MT ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17) :2236-2252